CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...